101 related articles for article (PubMed ID: 9143014)
1. Clinical presentation and patterns of regional cerebral atrophy related to the length of trinucleotide repeat expansion in patients with adult onset Huntington's disease.
Sieradzan K; Mann DM; Dodge A
Neurosci Lett; 1997 Mar; 225(1):45-8. PubMed ID: 9143014
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
[TBL] [Abstract][Full Text] [Related]
3. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.
Ruocco HH; Lopes-Cendes I; Li LM; Santos-Silva M; Cendes F
Braz J Med Biol Res; 2006 Aug; 39(8):1129-36. PubMed ID: 16906288
[TBL] [Abstract][Full Text] [Related]
4. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Dec; 50(6):373-80. PubMed ID: 11761463
[TBL] [Abstract][Full Text] [Related]
5. A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion.
Margolis RL; O'Hearn E; Rosenblatt A; Willour V; Holmes SE; Franz ML; Callahan C; Hwang HS; Troncoso JC; Ross CA
Ann Neurol; 2001 Sep; 50(3):373-80. PubMed ID: 11558794
[TBL] [Abstract][Full Text] [Related]
6. Regional specificity of brain atrophy in Huntington's disease.
Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
[TBL] [Abstract][Full Text] [Related]
7. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
[TBL] [Abstract][Full Text] [Related]
8. Regional subcortical shape analysis in premanifest Huntington's disease.
Tang X; Ross CA; Johnson H; Paulsen JS; Younes L; Albin RL; Ratnanather JT; Miller MI
Hum Brain Mapp; 2019 Apr; 40(5):1419-1433. PubMed ID: 30376191
[TBL] [Abstract][Full Text] [Related]
9. Variation of selective gray and white matter atrophy in Huntington's disease.
Jech R; Klempír J; Vymazal J; Zidovská J; Klempírová O; Růzicka E; Roth J
Mov Disord; 2007 Sep; 22(12):1783-9. PubMed ID: 17579363
[TBL] [Abstract][Full Text] [Related]
10. Trinucleotide repeat length and progression of illness in Huntington's disease.
Kieburtz K; MacDonald M; Shih C; Feigin A; Steinberg K; Bordwell K; Zimmerman C; Srinidhi J; Sotack J; Gusella J
J Med Genet; 1994 Nov; 31(11):872-4. PubMed ID: 7853373
[TBL] [Abstract][Full Text] [Related]
11. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.
Andrew SE; Goldberg YP; Kremer B; Telenius H; Theilmann J; Adam S; Starr E; Squitieri F; Lin B; Kalchman MA
Nat Genet; 1993 Aug; 4(4):398-403. PubMed ID: 8401589
[TBL] [Abstract][Full Text] [Related]
12. CAG repeat number governs the development rate of pathology in Huntington's disease.
Penney JB; Vonsattel JP; MacDonald ME; Gusella JF; Myers RH
Ann Neurol; 1997 May; 41(5):689-92. PubMed ID: 9153534
[TBL] [Abstract][Full Text] [Related]
13. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.
Mann DM; Oliver R; Snowden JS
Acta Neuropathol; 1993; 85(5):553-9. PubMed ID: 8493863
[TBL] [Abstract][Full Text] [Related]
14. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
[TBL] [Abstract][Full Text] [Related]
15. A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study.
Rosas HD; Reuter M; Doros G; Lee SY; Triggs T; Malarick K; Fischl B; Salat DH; Hersch SM
Mov Disord; 2011 Aug; 26(9):1691-7. PubMed ID: 21611979
[TBL] [Abstract][Full Text] [Related]
16. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset.
Trottier Y; Biancalana V; Mandel JL
J Med Genet; 1994 May; 31(5):377-82. PubMed ID: 8064815
[TBL] [Abstract][Full Text] [Related]
17. Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study.
Kassubek J; Juengling FD; Kioschies T; Henkel K; Karitzky J; Kramer B; Ecker D; Andrich J; Saft C; Kraus P; Aschoff AJ; Ludolph AC; Landwehrmeyer GB
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):213-20. PubMed ID: 14742591
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological Comparison of Adult Onset and Juvenile Huntington's Disease with Cerebellar Atrophy: A Report of a Father and Son.
Latimer CS; Flanagan ME; Cimino PJ; Jayadev S; Davis M; Hoffer ZS; Montine TJ; Gonzalez-Cuyar LF; Bird TD; Keene CD
J Huntingtons Dis; 2017; 6(4):337-348. PubMed ID: 29036832
[TBL] [Abstract][Full Text] [Related]
19. CAG repeat size and clinical presentation in Huntington's disease.
Ashizawa T; Wong LJ; Richards CS; Caskey CT; Jankovic J
Neurology; 1994 Jun; 44(6):1137-43. PubMed ID: 8208412
[TBL] [Abstract][Full Text] [Related]
20. The distribution of structural neuropathology in pre-clinical Huntington's disease.
Thieben MJ; Duggins AJ; Good CD; Gomes L; Mahant N; Richards F; McCusker E; Frackowiak RS
Brain; 2002 Aug; 125(Pt 8):1815-28. PubMed ID: 12135972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
